2011
DOI: 10.1016/j.neurobiolaging.2010.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Lack of association of PON polymorphisms with sporadic ALS in an Italian population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 25 publications
0
17
0
Order By: Relevance
“…Our study included four more studies; two articles on the PON1 Q192R polymorphism, with 722 more ALS patients and 624 more controls [9,10]; and two additional articles on the PON1 L55M polymorphism. Nonetheless, the results of our meta-analysis of the association of PON1 polymorphisms with ALS development were in agreement with the previous study.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Our study included four more studies; two articles on the PON1 Q192R polymorphism, with 722 more ALS patients and 624 more controls [9,10]; and two additional articles on the PON1 L55M polymorphism. Nonetheless, the results of our meta-analysis of the association of PON1 polymorphisms with ALS development were in agreement with the previous study.…”
Section: Discussionmentioning
confidence: 99%
“…Seven studies were excluded because they neither contain genotype data for the PON1 polymorphism nor duplicate data. Thus, eight studies met the inclusion criteria [9][10][11][12][13][14][15][16][17]. The meta-analysis considered eight studies for the PON1 Q192R polymorphism, with 2,831 patients and 3,123 controls; and seven studies for the PON1 L55M polymorphism with 2,693 patients and 2,952 controls ( Table 2; Fig.…”
Section: Studies Included In the Meta-analysismentioning
confidence: 99%
See 1 more Smart Citation
“…However, a meta-analysis including 4037 cases and 4609 controls from five casecontrol studies and several genome-wide association studies showed no significant association between PON polymorphisms and ALS (Wills et al, 2009). More recently, two other studies failed to detect association between PON polymorphisms and ALS (Ricci et al 2011;Zawislak et al, 2010). In a recent sequencing study, eight mutations in all three PON genes were identified in fALS and sALS patients (Ticozzi et al, 2010).…”
Section: Paraoxonase Genes (Pon)mentioning
confidence: 99%
“…For example, genetic variations have been identified in the coding and promoter region of the human PON1 locus which determines the catalytic activity and enzyme levels. Therefore, mutations that impair the ability of detoxifying PON1 may increase patient's susceptibility to organophosphate and potentially lead to the development of Amyotrophic Lateral Sclerosis (22). However, epidemiological and animal studies have not been able to establish a causal link between exposure to organophosphate and mutations in PON1 gene.…”
Section: Introductionmentioning
confidence: 99%